Form D · Biotechnology
Invectys, Inc.
Houston, TX · CIK 0001871302
Offering snapshot reported Oct 10, 2024 · SEC filing
- Reported sold
- $4M Offering amount: $4M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 30, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 10, 2024 | Initial | $4,000,000 | No comparison | 6 | SEC filing |
| Jul 15, 2021 | Initial | Yet to sell | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-526421
Convertible Promissory Notes and Warrants.
Source: Form D, filed Oct 10, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ivor Elfiri | Director |
| Shannon Fairbanks | Director |
| David Guyer | Director |
| Jake Kushner | Director, Executive |
| Cary Mc Nair | Director |
| Praveen Tyle | Director, Executive |
| Rosemary Williams | Executive |
| Maurizio Zanetti | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2415 West Alabama Suite 220
Houston, TX, 77098
Houston, TX, 77098